Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease.
AlQahtani M, Kumar N, Aljawder D, Abdulrahman A, Mohamed MW, Alnashaba F, Fayyad MA, Alshaikh F, Alsahaf F, Saeed S, Almahroos A, Abdulrahim Z, Otoom S, Atkin SL.
AlQahtani M, et al. Among authors: almahroos a.
Sci Rep. 2022 Mar 23;12(1):4925. doi: 10.1038/s41598-022-08794-w.
Sci Rep. 2022.
PMID: 35322077
Free PMC article.
Clinical Trial.